At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Multicenter Randomized Clinical Trial of 10 and 14 Days
In Brief
A Phase 4 clinical trial evaluating Amoxicillin, Clarithromycin, and 5 other interventions for Helicobacter Pylori Infection. Completed, enrolled 1,300 participants across 6 sites.
Detailed Summary
The researchers collect treatment-naive H.pylori-positive patients from the outpatient clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates, patient compliance and cost-effectiveness index of each group.
Study Details
Timeline
Interventions
Use according to the drug combination options selected by each center.
Use according to the drug combination options selected by each center.
Use according to the drug combination options selected by each center.
Use according to the drug combination options selected by each center.
Use according to the drug combination options selected by each center.
Use according to the drug combination options selected by each center.
Use according to the drug combination options selected by each center.